Diagnostic and therapeutic problems of isolated systolic hypertension

Area of Science:

• Cardiovascular Medicine
• Gerontology
• Pharmacology

Background:

• Isolated systolic hypertension (ISH) prevalence rises with age, posing significant cardiovascular risks.
• Despite known benefits, achieving adequate systolic blood pressure (SBP) control in ISH remains challenging with current treatments.
• Arterial stiffness, a consequence of vascular aging and neurohormonal changes, is a primary driver of elevated SBP.

Purpose of the Study:

• To highlight arterial stiffness as a critical determinant of SBP in aging populations.
• To emphasize the limitations of current antihypertensive therapies in addressing arterial stiffness.
• To advocate for the development of novel treatments targeting the neurohormonal mechanisms of vascular aging.

Main Methods:

• Review of extensive clinical data and research on isolated systolic hypertension.
• Analysis of the relationship between arterial stiffness, vascular aging, and elevated SBP.
• Evaluation of the efficacy of existing antihypertensive treatments on arterial stiffness.

Main Results:

• Arterial stiffness is independently associated with cardiovascular morbidity and mortality.
• Current antihypertensive medications demonstrate limited impact on reducing arterial stiffness.
• Neurohormonal alterations during vascular aging are central to increased arterial stiffness and SBP.

Conclusions:

• Arterial stiffness represents a crucial therapeutic target for managing isolated systolic hypertension.
• Novel therapies addressing neurohormonal pathways involved in vascular aging are needed.
• Future treatments focused on arterial stiffness may significantly improve SBP management and cardiovascular outcomes.